The RNA binding protein neuro‐oncological ventral antigen 1 (NOVA1) regulates IL-6 mRNA stability to enhance JAK2-STAT3 signaling in CRC

Siegel, 2017, Colorectal cancer statistics, CA A Cancer J. Clin., 67, 177, 10.3322/caac.21395

Monteiro, 2010, Cancer stemness and metastasis: therapeutic consequences and perspectives, Eur. J. Cancer, 46, 1198, 10.1016/j.ejca.2010.02.030

Pantel, 2004, Dissecting the metastatic cascade, Nat. Rev. Cancer, 4, 448, 10.1038/nrc1370

Neelamraju, 2018, Mutational landscape of RNA-binding proteins in human cancers, RNA Biol., 15, 115, 10.1080/15476286.2017.1391436

Heller, 2017, ssHMM: extracting intuitive sequence-structure motifs from high-throughput RNA-binding protein data, Nucleic Acids Res., 45, 11004, 10.1093/nar/gkx756

Xu, 2017, RNA binding protein Ybx2 regulates RNA stability during cold-induced Brown fat activation, Diabetes, 66, 2987, 10.2337/db17-0655

Li, 2017, Identification of high-confidence RNA regulatory elements by combinatorial classification of RNA-protein binding sites, Genome Biol., 18, 169, 10.1186/s13059-017-1298-8

Wurth, 2016, UNR/CSDE1 drives a post-transcriptional Program to promote melanoma invasion and metastasis, Cancer Cell, 30, 694, 10.1016/j.ccell.2016.10.004

Schiera, 2016, Extracellular vesicles shed by melanoma cells contain a modified form of H1.0 linker histone and H1.0 mRNA-binding proteins, Int. J. Oncol., 49, 1807, 10.3892/ijo.2016.3692

Roesch, 2005, Retinoblastoma-binding protein 2-homolog 1: a retinoblastoma-binding protein downregulated in malignant melanomas, Mod. Pathol., 18, 1249, 10.1038/modpathol.3800413

Xin, 2017, Neuro-oncological ventral antigen 1 (NOVA1): implications in neurological diseases and cancers, Cell Prolif, 50, 10.1111/cpr.12348

Kim, 2016, Upregulated neuro-oncological ventral antigen 1 (NOVA1) expression is specific to mature and immature T- and NK-cell lymphomas, J Pathol. Trans. Med., 50, 104, 10.4132/jptm.2016.02.08

Saito, 2016, NOVA2-mediated RNA regulation is required for axonal pathfinding during development, Elife, 5, 10.7554/eLife.14371

Jelen, 2007, Evolution of Nova-dependent splicing regulation in the brain, PLoS Genet., 3, 1838, 10.1371/journal.pgen.0030173

Fletcher, 1997, Mouse chromosomal locations of nine genes encoding homologs of human paraneoplastic neurologic disorder antigens, Genomics, 45, 313, 10.1006/geno.1997.4925

Kim, 2017, Implications of NOVA1 suppression within the microenvironment of gastric cancer: association with immune cell dysregulation, Gastric Cancer, 20, 438, 10.1007/s10120-016-0623-3

Zhi, 2014, MiR-181b-5p downregulates NOVA1 to suppress proliferation, migration and invasion and promote apoptosis in astrocytoma, PLoS One, 9, 10.1371/journal.pone.0109124

Gimenez, 2015, Quantitative proteomic analysis shows differentially expressed HSPB1 in glioblastoma as a discriminating short from long survival factor and NOVA1 as a differentiation factor between low-grade astrocytoma and oligodendroglioma, BMC Canc., 15, 481, 10.1186/s12885-015-1473-9

Zhang, 2016, RNA binding protein Nova1 promotes tumor growth in vivo and its potential mechanism as an oncogene may due to its interaction with GABAA Receptor-gamma2, J. Biomed. Sci., 23, 71, 10.1186/s12929-016-0288-6

Shen, 2015, MicroRNA-339, an epigenetic modulating target is involved in human gastric carcinogenesis through targeting NOVA1, FEBS Lett., 589, 3205, 10.1016/j.febslet.2015.09.009

Ni, 2019, MicroRNA-197-3p acts as a prognostic marker and inhibits cell invasion in hepatocellular carcinoma, Oncol. Lett., 17, 2317

Laughlin, 2008, Functional analysis of a tripartite stability element within the CD40 ligand 3' untranslated region, Immunology, 124, 368, 10.1111/j.1365-2567.2007.02783.x

Lucchesi, 2016, Modulation of the p53 family network by RNA-binding proteins, Transl. Cancer Res., 5, 676, 10.21037/tcr.2016.08.30

Hao, 2017, MicroRNAs and RNA binding protein regulators of microRNAs in the control of pluripotency and reprogramming, Curr. Opin. Genet. Dev., 46, 95, 10.1016/j.gde.2017.07.001

Pereira, 2017, RNA-binding proteins in cancer: old players and new actors, Trends Cancer, 3, 506, 10.1016/j.trecan.2017.05.003

Dang, 2017, Oncogenic activation of the RNA binding protein NELFE and MYC signaling in hepatocellular carcinoma, Cancer Cell, 32, 10.1016/j.ccell.2017.06.002

Fryssira, 2016, Partial monosomy14q involving FOXG1 and NOVA1 in an infant with microcephaly, seizures and severe developmental delay, Mol. Cytogenet., 9, 55, 10.1186/s13039-016-0269-1

Herve, 2016, MicroRNA screening identifies a link between NOVA1 expression and a low level of IKAP in familial dysautonomia, Dis. Model Mech., 9, 899, 10.1242/dmm.025841

Zhang, 2014, High expression of neuro-oncological ventral antigen 1 correlates with poor prognosis in hepatocellular carcinoma, PLoS One, 9

Abubaker, 2014, Targeted disruption of the JAK2/STAT3 pathway in combination with systemic administration of paclitaxel inhibits the priming of ovarian cancer stem cells leading to a reduced tumor burden, Front Oncol., 4, 75, 10.3389/fonc.2014.00075

Colomiere, 2009, Cross talk of signals between EGFR and IL-6R through JAK2/STAT3 mediate epithelial-mesenchymal transition in ovarian carcinomas, Br. J. Canc., 100, 134, 10.1038/sj.bjc.6604794

Wu, 2015, Long noncoding RNA lncTCF7, induced by IL-6/STAT3 transactivation, promotes hepatocellular carcinoma aggressiveness through epithelial-mesenchymal transition, J. Exp. Clin. Cancer Res., 34, 116, 10.1186/s13046-015-0229-3

Calabretta, 2015, Emerging roles of disordered sequences in RNA-binding proteins, Trends Biochem. Sci., 40, 662, 10.1016/j.tibs.2015.08.012